XBIO - Xenetic Biosciences EPS misses by $0.01 beats on revenue November, 12 2021 08:34 AM Xenetic Biosciences Inc. Xenetic Biosciences (NASDAQ:XBIO): Q3 GAAP EPS of -$0.13 misses by $0.01. Revenue of $0.35M (+191.7% Y/Y) beats by $0.15M. Press Release For further details see: Xenetic Biosciences EPS misses by $0.01, beats on revenue